María Teresa Arroyo Villarino

6PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingRehabilitation engineeringMetabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 02, 2025
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Antonio Giordano, Isabel Pérez-Martínez, Javier P Gisbert

|Nov 26, 2024
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).

María José García, Yanire Brenes, Miren Vicuña

|Aug 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU.

Mariam Aguas, Javier Del Hoyo, Raquel Vicente

|Sep 28, 2023
Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease.

Sandra García-Mateo, Samuel J Martínez-Domínguez, Carla Jerusalén Gargallo-Puyuelo

|Aug 12, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.

María Chaparro, Iria Baston-Rey, Estela Fernández Salgado

|Jul 30, 2020
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.

Iago Rodríguez-Lago, Javier Del Hoyo, Alexandre Pérez-Girbés

Pageof 1

Frequent Collaborators

4 joint publications

Javier P Gisbert

3 joint publications

María José García

3 joint publications

Raquel Vicente Lidón

3 joint publications

María Dolores Martin-Arranz